These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 19069497)
21. [Efficacy of using vitaprost in patients with infertility caused by chronic prostatitis]. Ziganshin OR; Bezpal'ko IuV; Kovalev IuN Urologiia; 2010; (6):50-4. PubMed ID: 21427996 [TBL] [Abstract][Full Text] [Related]
22. [The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis]. Kuzmenko AV; Vinnik YY; Kuzmenko VV; Gyaurgiev TA Urologiia; 2021 Jun; (3):70-74. PubMed ID: 34251104 [TBL] [Abstract][Full Text] [Related]
23. [Russian experience with Vitaprost Forte suppositories in patients with lower urinary tract symptoms and benign prostatic hyperplasia: comparative analysis of studies]. Korneev IA Urologiia; 2017 Jul; (3):138-144. PubMed ID: 28845952 [TBL] [Abstract][Full Text] [Related]
24. [Cernilton in the treatment of prostatic adenoma and chronic prostatitis]. Aslamazov EG; Akhvlediani ND; Vinarov AZ; Aliaev IuG Urologiia; 2007; (1):52, 54-6. PubMed ID: 17472001 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia. Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042 [TBL] [Abstract][Full Text] [Related]
26. [CORRECTION OF BLOOD CIRCULATION IN THE PROSTATE IN PATIENTS WITH CHRONIC PROSTATITIS ASSOCIATED WITH UROGENITAL INFECTIONS]. Kondrat'eva JS; Nejmark AI; Zheltikova JD; Subbotin EA Urologiia; 2015; (2):68-70, 72-3. PubMed ID: 26237811 [TBL] [Abstract][Full Text] [Related]
27. [Effectiveness of Vitaprost Plus in the treatment of patients with chronic bacterial prostatitis]. Logvinov LA; Kudriavtsev IuV; Kumachev KV; Popov SV; Chernikov SS Urologiia; 2013; (6):62-4, 66. PubMed ID: 24649767 [TBL] [Abstract][Full Text] [Related]
28. [Our experience in the use of prostatilen in urology]. Al'-Shukri SKh; Bobkov IuA; Gorbachev AG; Kuz'min IV; Tkachuk VN Urologiia; 2003; (6):32-6. PubMed ID: 14708243 [TBL] [Abstract][Full Text] [Related]
29. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia]. Pawlicki B; ZieliĆski H; Dabrowski M Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689 [TBL] [Abstract][Full Text] [Related]
30. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis]. Wu XJ; Yang LY; Zhang XZ Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752 [TBL] [Abstract][Full Text] [Related]
31. Cefminox sodium penetration into prostatic tissue with and without inflammation. Sasagawa I; Yamaguchi O; Shiraiwa Y Int Urol Nephrol; 1991; 23(6):569-72. PubMed ID: 1722784 [TBL] [Abstract][Full Text] [Related]
32. [Vitaprost plus in the treatment of chronic bacterial prostatitis]. Lopatkin NA; Kamalov AA; Mazo EB; Kozdoba AS; Popov SV; Efremov EA; Dorofeev SD; Mel'nik IaI; Okhobotov DA Urologiia; 2009; (3):54-61. PubMed ID: 19670818 [TBL] [Abstract][Full Text] [Related]
34. [Changes in microcirculation of the urinary bladder in patients with stage II prostatic adenoma depending on the treatment method]. Pavlov VN; Kazikhinurov AA; Ishemgulov RR; Mustafin AT Urologiia; 2008; (1):31-2, 34-5. PubMed ID: 18649676 [TBL] [Abstract][Full Text] [Related]